CEL-SCI (FRA:LSRM) Current Accrued Expense : €1.18 Mil (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is CEL-SCI Current Accrued Expense?

CEL-SCI's Current Accrued Expense for the quarter that ended in Jun. 2024 was €1.18 Mil.

CEL-SCI's quarterly Current Accrued Expense increased from Dec. 2023 (€0.91 Mil) to Mar. 2024 (€1.12 Mil) and increased from Mar. 2024 (€1.12 Mil) to Jun. 2024 (€1.18 Mil).

CEL-SCI's annual Current Accrued Expense increased from Sep. 2021 (€0.73 Mil) to Sep. 2022 (€0.85 Mil) and increased from Sep. 2022 (€0.85 Mil) to Sep. 2023 (€0.98 Mil).

CEL-SCI Current Accrued Expense Historical Data

The historical data trend for CEL-SCI's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Current Accrued Expense Chart

CEL-SCI Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Current Accrued Expense

Get a 7-Day Free Trial

0.03

0.43

0.73

0.85

0.98

CEL-SCI Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Accrued Expense	Get a 7-Day Free Trial															1.05	0.98	0.91	1.12	1.18

CEL-SCI Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

CEL-SCI Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of CEL-SCI's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CEL-SCI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CVM:USA LSRM:Germany

Address

8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182

Website

https://www.cel-sci.com

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI Headlines

No Headlines